GoldenGolden
Advanced Search
LogicBio Therapeutics

LogicBio Therapeutics

LogicBio Therapeutics is a Cambridge, Massachusetts-based biotechnology company.

LogicBio Therapeutics is a genome editing company developing genetic medicines for treating rare pediatric diseases.

Timeline

April 27, 2021
LogicBio Therapeutics announces research collaboration with Daiichi Sankyo.

June 2017
LogicBio Therapeutics raises a $45,000,000 series B round from Andera Partners, Arix Bioscience plc, OrbiMed, OrbiMed Israel Partners, Pontifax Venture Capital and SBI Group.
January 20, 2016
LogicBio Therapeutics raises a $4,000,000 series A round from OrbiMed.
2014
LogicBio Therapeutics was founded by Adi Barzel, Mary Kay and Tomasz Lisowski.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
LogicBio Therapeutics, Inc.
June 1, 2021
www.prnewswire.com:443
/PRNewswire/ -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to...
May 19, 2021
BioSpace
LogicBio Therapeutics Promotes Daniel Gruskin, MD, to Chief Medical Officer and Announces Additional Leadership Appointments - read this article along with other careers information, tips and advice on BioSpace
Alex Keown
May 14, 2021
BioSpace
Biopharma and life sciences companies strengthen their leadership teams and boards with Movers & Shakers.
May 10, 2021
BioSpace
LogicBio Therapeutics Strengthens Management Team with Key Appointments - read this article along with other careers information, tips and advice on BioSpace
LogicBio Therapeutics, Inc.
May 10, 2021
www.prnewswire.com:443
/PRNewswire/ -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to...
LogicBio Therapeutics, Inc.
May 3, 2021
www.prnewswire.com:443
/PRNewswire/ -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to...
Alex Keown
April 29, 2021
BioSpace
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Alex Keown
April 29, 2021
BioSpace
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
April 27, 2021
BioSpace
LogicBio Therapeutics Announces Clinical and Corporate Updates - read this article along with other careers information, tips and advice on BioSpace
April 27, 2021
BioSpace
LogicBio Therapeutics Announces Strategic Collaboration and Option Agreement with CANbridge Pharmaceuticals Leveraging Gene Editing and Gene Delivery Platforms - read this article along with other careers information, tips and advice on BioSpace
April 27, 2021
BioSpace
LogicBio Therapeutics Announces Research Collaboration with Daiichi Sankyo - read this article along with other careers information, tips and advice on BioSpace
April 27, 2021
BioSpace
CANbridge Pharmaceuticals Announces Strategic Collaboration with LogicBio Therapeutics and Licenses to Gene Delivery and Editing Platforms - read this article along with other careers information, tips and advice on BioSpace
LogicBio Therapeutics, Inc.
December 22, 2020
www.prnewswire.com:443
/PRNewswire/ -- LogicBio Therapeutics, Inc. (Nasdaq: LOGC), a clinical stage genetic medicines company, today announced the appointment of Cecilia Jones as the...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.